Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-766-0 | CAS number: 87-69-4
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
The FDA report, mutagenic evaluation of compound FDA 71 -55, comprises several studies investigating genotoxicity of this substance in vitro and in vivo. In thein vitro studies, 4 host-mediated assays including two bacteria (S. typhimurium) and two yeast (Saccharomyces cerevisiae) tests, and a mammalian chromosome aberration test (Human embryonic lung cultures) were conducted at different concentration levels. In the in vivo studies, two dominant lethal tests and two mammalian bone marrow chromosome aberration tests were carried out in different series of concentrations in rats. No genetic toxicity was found in those tests in all investigated concentrations. So it can be concluded that L (+)-tartaric acid is non-mutagenic.
Short description of key information:
no genetic toxicity of tartaric acid was found through in vitro and in vivo experiments.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Route: .live2